BioMarker Searching Out Venture Capital

As reported on the Life Extension Foundation website, BioMarker Pharmaceuticals is on the path to obtaining first round venture funding. They have a strong case and I'm certainly rooting for them. BioMarker, as you might recall, is working on translating proven healthy life extension via calorie restriction into genetic therapies for longer, healthier lives. This is one to watch, since venture firms tend to invest in sets: if BioMarker gets funding, there will likely be a dozen more real anti-aging research companies funded within the next few years.

Link: http://www.lef.org/magazine/mag2003/2003_preprint_bio2_01.html

Comments

Post a comment; thoughtful, considered opinions are valued. Comments incorporating ad hominem attacks, advertising, and other forms of inappropriate behavior are likely to be deleted.

Note that there is a comment feed for those who like to keep up with conversations.